LingVo.club
📖+40 XP
🎧+25 XP
+45 XP
Cherry compounds may slow triple-negative breast cancer — Level B2 — close-up photography of red and yellow flower

Cherry compounds may slow triple-negative breast cancerCEFR B2

27 Feb 2026

Adapted from Texas A&M University, Futurity CC BY 4.0

Photo by Ramesh L T, Unsplash

Level B2 – Upper-intermediate
5 min
278 words

Researchers at Texas A&M University College of Agriculture and Life Sciences, Texas A&M AgriLife Research and the College of Veterinary Medicine and Biomedical Sciences (VMBS) examined whether anthocyanins—natural pigments in dark sweet cherries—can affect triple-negative breast cancer in mice. The study went beyond measuring primary tumour size and assessed both tumour growth and metastatic spread, since metastasis is the main cause of cancer deaths.

Mice were split into four groups: a control group; one receiving anthocyanins before tumour implantation (a preventive approach); one given the chemotherapy drug doxorubicin after tumours formed; and one receiving both anthocyanins and chemotherapy to test for a potential enhancing effect. Anthocyanin treatment before implantation slowed tumour growth without noticeable side effects and those mice continued to gain weight. Chemotherapy alone sometimes caused weight loss and slowed tumour growth later, while the combination slowed growth earlier and mice maintained weight.

At the molecular level, anthocyanins alone or combined with chemotherapy reduced the activity of genes associated with cancer spread and therapy resistance. Treatment reduced lung metastasis more than no treatment or chemotherapy alone and also lowered the probability of spread to the liver, heart, kidneys and spleen, although tumour number and size varied between animals. Histology analysis examined mitotic index, tissue necrosis and immune cell infiltration, including T lymphocytes, and researchers noted variation in tumour behaviour and immune response across samples.

The investigators conclude that diet-derived compounds may target processes not fully addressed by standard therapies, but they emphasise that more research is required on safety, absorption and how anthocyanins might work alongside existing cancer treatments. The findings appear in the International Journal of Molecular Sciences.

Difficult words

  • anthocyaninNatural pigment found in dark red fruits
    anthocyanins
  • metastasisSpread of cancer from original tumour to elsewhere
  • chemotherapyDrug treatment intended to kill cancer cells
  • doxorubicinA chemotherapy drug used to treat cancers
  • histologyStudy of tissues under a microscope
  • necrosisDeath of cells or tissue in the body
  • absorptionProcess by which a substance enters the body

Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.

Discussion questions

  • What are the potential benefits and risks of adding diet-derived compounds like anthocyanins to cancer treatment? Give reasons based on the article.
  • How reliable do you think results from mouse studies are for human treatment decisions? What additional research would you want to see?
  • If you were designing a follow-up study, what would you investigate about safety, absorption or combination with chemotherapy? Explain your priorities.

Related articles